Ali, Rooble https://orcid.org/0009-0001-0239-6796
Walker, Susan https://orcid.org/0000-0002-7348-8284
Nyikavaranda, Patrick https://orcid.org/0000-0002-9896-6078
Downs, Johnny https://orcid.org/0000-0002-8061-295X
Patel, Rashmi https://orcid.org/0000-0002-9259-8788
Khondoker, Mizanur https://orcid.org/0000-0002-1801-1635
Bhui, Kamaldeep https://orcid.org/0000-0002-9205-2144
Hayes, Richard D. https://orcid.org/0000-0003-4453-244X
de Freitas, Daniela Fonseca https://orcid.org/0000-0002-8876-4595
Funding for this research was provided by:
National Institute for Health Research (DRF-2017–10–147, CS-2018–18-ST2-014, NIHR301690)
Applied Research Collaboration Kent, Surrey, and Sussex
Medical Research Council (MR/L017105/1, MR/S003118/1)
NIHR Maudsley Biomedical Research Centre (NA, NA)
Lankelly Chase Foundation (NA)
Article History
Received: 21 December 2023
Accepted: 30 March 2025
First Online: 16 April 2025
Declarations
:
: In the past 5 years, for works not related to this manuscript, RP has participated in a Scientific Advisory Board for Boehringer Ingelheim, has received grant funding from Janssen, and has received consulting fees from Holmusk, Akrivia Health, Columbia Data Analytics, Clinilabs, Social Finance, Boehringer Ingelheim, Bristol Myers Squibb, Supernus, Teva and Otsuka. In the past 5 years, for works not related to this manuscript, RDH has received research funding from Roche, Pfizer, Janssen and H Lundbeck. In the past 5 years, for works not related to this manuscript, DFdF received funds from the NIHR Maudsley Biomedical Research Centre, the UK Department of Health and Social Care, Janssen Research & Development LLC, and H. Lundbeck A/S.